Report: Pharma manufacturing "best bet" for college grads

GlaxoSmithKline is sweetening the pot for top-notch UK college grads seeking a career in big pharma. It's offering to pay select graduates as much as $44,000 in tuition fees for joining GSK's "post-graduate" training program and then working at the big pharma for the next two years.

Through the tuition payment program, GSK targets the top 50 to 100 graduates from among those who apply to the company and pass muster. CEO Andrew Witty (photo) says he wants to get "the absolute best possible graduates we can," in the UK trade journal, LabNews.

Separately, the Christian Science Monitor reports that pharma manufacturing is among several "best bet" categories for college graduates this spring.  A survey conducted by the National Association of Colleges and Employers indicates that this spring's job outlook for graduates is the best since 2007.

Survey respondents report an average of 21 applications for each job posting, down from last year's 40.  

- here's the GSK story
- see the CSM article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.